Methods and compositions for soft anticholinergic esters
US11951093B2 · kind B2 · utility
0Cited by
13References
58Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jun 23, 2022 |
| Grant date | Apr 9, 2024 |
| Priority date | — |
| Expiry date | Jun 23, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D207/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Intra-oral formulations comprising soft anticholinergic alkyl esters are useful for treating excessive drooling conditions in subjects, such as humans, suffering from sialorrhea. Preferably, at least one soft anticholinergic ester is provided in an effective amount or concentration in an anhydrous intra-oral formulation that can inhibit excessive drooling resulting from a condition known as sialorrhea.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.